May 16 (Reuters) - Biomarin Pharmaceutical Inc BMRN.O:
BIOMARIN STRENGTHENS ENZYME THERAPY BUSINESS WITH ACQUISITION OF INOZYME PHARMA
INOZYME PHARMA INC - BIOMARIN TO BUY INOZYME FOR $270 MILLION
INOZYME PHARMA INC - BIOMARIN REAFFIRMS 2025 FINANCIAL GUIDANCE
Source text: ID:nPn7HZbjva
Further company coverage: BMRN.O
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.